Published Online: Saturday, December 1, 2007

Seniors enrolled in the Medicare Part D drug program will see their monthly premiums rise by an average of 21% unless they shop around for cheaper plans, according to a new analysis by researchers at Avalere Health. The cost of the drug program for upper-income Medicare recipients, however, will rise even higher under a new plan being floated around Washington.

Avalere?s analysis of federal data released by the Centers for Medicare & Medicaid Services found that 8 of the top 10 prescription drug plan sponsors in Medicare have increased their premiums for 2008. The 2 companies holding the line on premiums are: CVS Caremark?s SilverScript plan and First Health?s Part D Premier plan, said the researchers.

The cost of drug coverage could rise even more sharply for higher income seniors under a means test proposal being considered by the Bush administration. Under the plan, Medicare beneficiaries with annual incomes of >$80,000 would be required to pay additional fees to participate in the drug program.

Sen John Ensign (R, Nev) is developing a legislative proposal incorporating the plan, which could reduce the cost of Medicare Part D to taxpayers by billions of dollars.

Latest Articles
Beverly Schaefer, RPh, of Katterman's Sand Point Pharmacy in Seattle, Washington, shares some fun tips on how to encourage patients who travel to come to your pharmacy for supplies.
Donnie Calhoun, RPh, PD, National Community Pharmacists Association (NCPA) Foundation vice president, discusses how pharmacists can prepare themselves and their business before, during, and after a disaster.
Ken Whittemore Jr, Surescript's senior vice president of professional and regulatory affairs, talks about some new transactions available that can help pharmacists.
In case you got caught up in the Thanksgiving holiday rush, here are the top trending stories you may have missed in November:
Latest Issues